{
    "data": [
        {
            "id": "4511527",
            "title": "Cardinal Health surges as it raises FY 2026 EPS guidance",
            "description": "<html><body><ul>\n<li>Cardinal Health (<span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/CAH\" title=\"Cardinal Health, Inc.\">CAH</a></span></span></span>) is <span style=\"color: #008000;\">up ~13%</span> in Thursday trading after raising its EPS forecast for fiscal year 2026.</li>\n<li>The drug wholesaler now sees non-GAAP EPS of $9.65 to $9.85, from $9.30 to $9.50 previous. Consensus is $9.43.</li>\n<li>Shares are <span style=\"color: #ff0000;\">up ~13%</span> in Thursday trading. </li>\n<li>Cardinal Health delivered strong FY26 Q1 results, <a href=\"https://seekingalpha.com/news/4511159-cardinal-health-beats-q1-estimates-raises-guidance\" target=\"_self\" title=\"beating\">beating</a> on both lines.</li>\n<li>The company had double-digit profit growth across all five operating segments, with CEO Jason Hollar highlighting the Pharmaceutical and Specialty Solutions business in an <a href=\"https://seekingalpha.com/news/4511524-cardinal-health-raises-2026-eps-guidance-to-9_65-9_85-amid-strong-double-digit-segment-growth\" target=\"_self\" title=\"earnings call\">earnings call</a>.</li>\n<li>As a result, Cardinal Health is also boosting its profit growth outlook for the fiscal year to 16% to 19%, from 11% to 13% prior.</li>\n<li>Year over year, non-GAAP operating earnings grew 37% to $857M, with non-GAAP EPS up 36% to $2.55.</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511527-cardinal-health-surges-raises-fy-2026-eps-guidance",
            "pub_date": "2025-10-31 02:15:48",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511630",
            "title": "Thryv updates 2025 SaaS revenue guidance to $460M-$463M as business transformation advances with AI and vertical expansion",
            "description": "<html><body><p>Earnings Call Insights: Thryv Holdings (THRY) Q3 2025</p>\n<h3>Management View</h3>\n<ul>\n<li>Joe Walsh, Chairman &amp; CEO, shared updates on Thryv's ongoing business transformation, emphasizing the integration of Keap and the strengthening of the partner ecosystem. Walsh described the recent Grow Conference as pivotal: \"This partner update was like Christmas, us delivering on the value that they were looking for. And so, I have better expectations as we go into '26. I think these partners are pretty impressed at the pace at which we are delivering and innovating the software.\"</li>\n<li>Walsh highlighted the success of Marketing Center, noting it is \"our fastest-selling product\" and plays a central role in the company's \"market, sell, and grow\" strategy. He observed significant interest from both existing and prospective customers, with many using Marketing Center alongside competitors’ CRMs.</li>\n<li>AI advancements were cited as a major tailwind: \"We're rolling out lots of AI within the software...AI is being used throughout the product to make it easier for small business people, kind of meet them where they are.\"</li>\n<li>Walsh announced the appointment of Sean Wechter as Chief Technology Officer, stating, \"He is all AI all the time. And we're really excited about what we think we can do with Sean in the year ahead to really up-level even further our integration of AI.\"</li>\n<li>CFO Paul Rouse reported, \"SaaS reported revenue was $115.9 million in the third quarter, representing an increase of 33% year-over-year. Keap contributed $16.8 million in the third quarter. Excluding Keap, Thryv SaaS business grew 14% year-over-year.\"</li>\n<li>Rouse also noted, \"We ended the third quarter with 103,000 SaaS subscribers, including 13,000 from Keap, representing a 7% increase year-over-year.\"</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>For Q4 2025, SaaS revenue is expected in the range of $118 million to $121 million. Full year 2025 SaaS revenue guidance is updated to a range of $460 million to $463 million.</li>\n<li>For Q4, SaaS adjusted EBITDA is expected in the range of $19.2 million to $21.2 million. Full year SaaS adjusted EBITDA guidance is raised to a range of $73 million to $75 million.</li>\n<li>Rouse stated, \"For the full year, we expect Marketing Services revenue in the range of $323 million to $325 million.\" Marketing Services adjusted EBITDA guidance was updated to a range of $76 million to $78 million.</li>\n<li>Management communicated a continued strategic focus on ramping product adoption and verticalization, with particular momentum in home services and HVAC.</li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li>Rouse reported that SaaS adjusted gross margin increased 80 basis points year-over-year, reaching 73%.</li>\n<li>SaaS adjusted EBITDA was $19.6 million in Q3, resulting in an adjusted EBITDA margin of 17%.</li>\n<li>ARPU for SaaS reached $365 overall, with Thryv at $355 and Keap at $437. Multiproduct adoption accelerated, with 17,000 clients using two or more SaaS products, representing 20% of the base.</li>\n<li>Marketing Services revenue for the quarter was $85.7 million. Marketing Services adjusted EBITDA was $21.2 million, with an adjusted EBITDA margin of 25%.</li>\n<li>Total company billings were $184.2 million, down 4% year-over-year. Free cash flow for the quarter was $14.6 million, with year-to-date free cash flow at $18.8 million. Net debt decreased by $9 million to $265 million, with a leverage ratio of 1.9x.</li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Scott Berg, Needham &amp; Company: Asked about SaaS growth coming in at the low end of guidance and drivers behind this. Walsh responded that execution \"was a smidge shy of where we wanted to be,\" and stated, \"I can't blame anything outside at all.\"</li>\n<li>Berg followed up on partner ecosystem improvements. Walsh explained that partner morale is \"rising beautifully right now,\" after a year of focused investment and engagement.</li>\n<li>Jason Kreyer, Craig-Hallum: Inquired about the customer environment and impact of macro trends. Walsh said, \"We're not that economically sensitive...when we don't deliver, it's mostly our fault.\"</li>\n<li>Kreyer also asked about the impact of the vertical sales emphasis. Walsh indicated the push into verticals such as HVAC is aimed at raising ARPU and targeting larger, more stable clients, with early vertical sales \"coming in more like the 8,000 that we're going for.\"</li>\n<li>Alinda Li, William Blair: Asked about strategies under the new CTO and operational efficiency. Walsh noted an acceleration in product development and integration capabilities under Wechter.</li>\n<li>Zach Cummins, B. Riley: Sought detail on keeping clients visible in answer-based engines. Walsh described answer engines as a \"tailwind for us,\" emphasizing their ability to drive leads and value.</li>\n<li>Matthew Swanson, RBC: Questioned trends within the higher-spending SaaS client cohort. Walsh highlighted lower churn and higher product adoption among clients spending $400 or more per month.</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analysts expressed a mix of cautious inquiry and optimism, with questions focused on growth, execution, and client trends. The tone was neutral to slightly positive, with an emphasis on clarifying strategic direction and operational details.</li>\n<li>Management's sentiment was confident in prepared remarks, emphasizing transformation, AI, and product innovation. During Q&amp;A, Walsh acknowledged minor execution shortfalls but maintained a positive outlook, frequently referencing improvements and future expectations. Direct quotes such as \"I have better expectations as we go into '26\" and \"I think some of these partners work across different tools than just Keap...they're turning back our way more excited about what we're doing\" reflect this confidence.</li>\n<li>Compared to the previous quarter, management's tone remained optimistic but more focused on operational execution and partner engagement. Analysts' tone was more probing regarding execution and product adoption.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>Q3 guidance for SaaS revenue was lowered to $115.9 million actual, compared to Q2's guidance range of $116 million to $117 million. SaaS adjusted EBITDA in Q3 ($19.6 million) came in above the previous quarter's Q3 guidance range.</li>\n<li>Full year SaaS revenue guidance is now $460 million to $463 million, narrowed from Q2's $460 million to $465 million range. SaaS adjusted EBITDA guidance increased from $70.5 million-$73.5 million in Q2 to $73 million-$75 million in Q3.</li>\n<li>ARPU continued to expand, and focus shifted further to higher-value, multiproduct clients. Net revenue retention declined to 94% from 103%, attributed to legacy client transitions.</li>\n<li>Strategic focus continues to shift toward verticalization and moving upmarket, while continued integration of AI and the onboarding of the new CTO signal further acceleration in product development.</li>\n<li>Analysts in Q3 focused more on executional details and partner channel progress, while in Q2, questions centered on capital allocation and new product introductions.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Management cited \"temporary noise\" in SaaS metrics due to the migration of legacy marketing services clients and the resulting impact on ARPU and NRR.</li>\n<li>The transition off older tech platforms is expected to generate ongoing short-term volatility in metrics.</li>\n<li>Analyst concerns centered on execution, particularly the slight miss at the low end of SaaS guidance and the pace of partner channel improvement.</li>\n<li>Management stated, \"We are making steady progress building a solid software client base with strong underlying fundamentals,\" and emphasized that declines in Marketing Services billings are intentional and managed as part of the transformation.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Thryv management highlighted accelerated AI integration, increasing multiproduct adoption, and a strategic focus on vertical solutions as key drivers in the business transformation. While legacy client transitions and executional challenges created some noise in metrics this quarter, management reaffirmed its commitment to upmarket growth, operational efficiency, and the partner ecosystem, with raised full-year SaaS adjusted EBITDA guidance underscoring confidence in sustainable profitability and ongoing transformation into a leading SaaS provider.</p>\n<p><a href=\"https://seekingalpha.com/symbol/thry/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511630-thryv-updates-2025-saas-revenue-guidance-to-460m-463m-as-business-transformation-advances",
            "pub_date": "2025-10-31 02:10:53",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511629",
            "title": "Agios outlines Q4 2025 PYRUKYND milestones and anticipates U.S. thalassemia approval amid global expansion",
            "description": "<html><body><p>Earnings Call Insights: Agios Pharmaceuticals (AGIO) Q3 2025  </p>\n<h3>Management View</h3>\n<ul>\n<li>Brian Goff, CEO, emphasized \"steady progress and a focused strategy,\" highlighting \"multiple high-value catalysts in the coming months that position PYRUKYND, our foundational PK activator to achieve its multibillion-dollar potential across PK deficiency, thalassemia and sickle cell disease.\" He reported the FDA's \"recent request for a REMS program\" and noted the PDUFA date for PYRUKYND thalassemia supplemental NDA has been extended to December 7. He also stated, \"We look forward to sharing top line results from the RISE UP Phase III trial of PYRUKYND in sickle cell disease by year-end.\"</li>\n<li>Goff announced global progress with \"approval for PYRUKYND in adults with thalassemia in Saudi Arabia, our first global regulatory approval for this indication,\" and a \"positive CHMP opinion recommending PYRUKYND for marketing authorization in Europe.\"</li>\n<li>The company reported \"$12.9 million in net revenue, underscoring the strong value proposition of PYRUKYND.\"</li>\n<li>Cecilia Jones, CFO, stated, \"Third quarter net PYRUKYND revenue was $12.9 million, an increase of 44% compared to $9 million in the third quarter of 2024 and an increase of 3% compared to $12.5 million in the second quarter of 2025.\"</li>\n<li>Jones affirmed, \"On a full year basis, given the strong execution of our sales force to date, we anticipate net revenues in 2025 to show robust growth compared to 2024, although we recognize this growth is on a relatively small revenue base.\"</li>\n<li>She highlighted a \"strong balance sheet with approximately $1.3 billion in cash and investments.\"</li>\n<li>Tsveta Milanova, Chief Commercial Officer, noted \"262 patients have completed prescription enrollment forms, including 14 in the third quarter\" and \"149 patients currently on therapy, up 5% from the second quarter.\"</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>The company expects \"fourth quarter performance will benefit from an additional ordering week compared to the third quarter and we anticipate PYRUKYND net revenue will continue to reflect continued focus on PK deficiency ahead of potential approval for thalassemia in the U.S.\" (Jones)</li>\n<li>Full-year net revenues in 2025 are anticipated \"to show robust growth compared to 2024.\" (Jones)</li>\n<li>The team remains \"confident in our ability to deliver a successful launch\" for PYRUKYND in thalassemia, pending regulatory approval (Milanova).</li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li>Third quarter net PYRUKYND revenue was $12.9 million.</li>\n<li>Cost of sales for the quarter was $1.7 million; R&amp;D expenses were $86.8 million; SG&amp;A expenses were $41.3 million.</li>\n<li>The company ended the quarter with cash, cash equivalents and marketable securities of approximately $1.3 billion.</li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Eric Schmidt, Cantor Fitzgerald: Asked about the REMS program details and business development strategy. Sarah Gheuens, Chief Medical Officer, responded, \"We per process don't comment on the details of REMS in the label. However, indeed, to your point, there are many different forms of REMS... it will include monitoring and some form of education.\" Goff said, \"Our pursuit really is not timed to anything in particular... our sweet spot, of course, is rare diseases.\"</li>\n<li>Alec Stranahan, BofA Securities: Inquired about liver monitoring requirements in different geographies and commercial implications. Gheuens explained for Saudi, \"it's in line with our proposal of once-a-month monitoring for the first 6 months\" and said for Europe, \"the label will only be final when you have the EC decision.\" Milanova added, \"We don't anticipate that to be a barrier to prescribing or have an impact on our commercial opportunity.\"</li>\n<li>Emily Bodnar, H.C. Wainwright: Asked about positive data for low-risk MDS and the cadence for European thalassemia launch. Gheuens said, \"we were able to announce enrollment of our Phase IIb trial today... there is a huge unmet need for this patient population.\" Milanova described the European launch process as requiring \"12 to 18 months\" for pricing and reimbursement after regulatory approval.</li>\n<li>Marc Frahm, TD Cowen: Queried about liver events in PKR trials and commercial demand in the Gulf. Gheuens stated, \"safety profile remains exactly the same as when we declared this hepatocellular injury risk and we have not observed anything... that warrants us to update the safety profile.\" Milanova noted demand is strong but access is slow due to national procedures.</li>\n<li>Tessa Romero, JPMorgan: Asked about timing for RISE UP top line data. Goff responded, \"we're on track for that data by year-end.\"</li>\n<li>Lydia (for Salveen Richter, Goldman Sachs): Questioned REMS program implications for other indications. Goff clarified, \"the REMS request has been specific to thalassemia.\"</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analysts maintained a neutral to slightly positive tone, focusing on regulatory processes, risk monitoring, and the pace of global launches, with repeated questions about REMS and regulatory timing.</li>\n<li>Management projected confidence in both prepared remarks and Q&amp;A, with statements such as \"we are well positioned\" and \"we remain confident\" (Goff, Milanova). During Q&amp;A, management remained measured and avoided specifics on regulatory matters, often reiterating regulatory processes and timelines.</li>\n<li>Compared to the previous quarter, the tone remains confident and focused on execution, with an increased emphasis on regulatory hurdles and market access challenges.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>The current quarter featured the PDUFA date extension for PYRUKYND in thalassemia to December 7, whereas the previous quarter anticipated the original September 7 date.</li>\n<li>Third quarter net revenue rose slightly quarter-over-quarter ($12.9 million in Q3 vs. $12.5 million in Q2), with patient enrollments and those on therapy both increasing.</li>\n<li>SG&amp;A expenses decreased compared to Q2, while R&amp;D expenses were lower than the previous quarter, partly due to the absence of a milestone payment seen in Q2.</li>\n<li>Strategic focus shifted to global regulatory and launch milestones, with new international approvals secured and a positive European opinion.</li>\n<li>Analysts in both quarters focused on regulatory updates and commercial launch readiness, but this quarter included more granular questions about REMS and regional launch processes.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Management cited the ongoing FDA review and REMS program requirements as key challenges.</li>\n<li>Milanova acknowledged the slow patient access and reimbursement processes in international markets, particularly in Saudi Arabia and Europe.</li>\n<li>Gheuens reiterated the company's vigilance regarding hepatocellular injury risk, stating no new safety concerns had emerged.</li>\n<li>Analysts consistently probed for potential regulatory barriers, commercial uptake risks, and implications of REMS programs across indications.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Agios Pharmaceuticals highlighted steady commercial growth for PYRUKYND, with sequential increases in revenue and patient uptake, while signaling confidence in achieving a successful U.S. launch for thalassemia following the PDUFA date extension to December 7. The company emphasized its robust cash position and disciplined strategic investments supporting both near-term milestones and long-term pipeline expansion. Management remains focused on regulatory progress, commercial execution, and addressing the significant unmet needs in rare diseases, with key data readouts and regulatory decisions expected in the coming months.</p>\n<p><a href=\"https://seekingalpha.com/symbol/agio/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511629-agios-outlines-q4-2025-pyrukynd-milestones-and-anticipates-u-s-thalassemia-approval-amid",
            "pub_date": "2025-10-31 02:10:53",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511607",
            "title": "Meta sheds $220B in market cap, VR unit hits $73B in cumulative losses",
            "description": "<html><body><p>Class A shares of Meta Platforms (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/META\" title=\"Meta Platforms, Inc.\">META</a></span>) on Thursday slumped as much as <span style=\"color: #ff0000;\">-13.5%</span> to $650.25, after the Facebook parent booked a nearly $16B one-time income tax charge in its quarterly results. At that session low, the stock had lost more than $220B in market value.</p>\n<p>META was last <span style=\"color: #ff0000;\">-10.3%</span> at $674.51 in afternoon trading, on track to shed more than $168B in market cap.</p>\n<p>This would be Meta (<a href=\"https://seekingalpha.com/symbol/META\" title=\"Meta Platforms, Inc.\">META</a>) stock's largest single-day market cap plunge since a more than $230B <a href=\"https://seekingalpha.com/news/3795649-metafacebook-faceplant-set-to-wipe-out-most-equity-value-ever\" target=\"_blank\" title=\"wipeout\">wipeout</a> back in February 2022, after the company's Q4 2021 results.</p>\n<p>Analysts on Thursday <a href=\"https://seekingalpha.com/news/4511469-analysts-largely-impressed-with-metas-q3-but-ai-spending-plans-remind-of-metaverse-days\" target=\"_blank\" title=\"expressed\">expressed</a> concerns over Meta's (<a href=\"https://seekingalpha.com/symbol/META\" title=\"Meta Platforms, Inc.\">META</a>) aggressive capital spending in artificial intelligence, with Oppenheimer saying the investment was reminiscent of the company's massive spending on its Metaverse in 2021 and 2022. </p>\n<p>Speaking of the Metaverse, losses at Reality Labs, META's segment that houses its augmented reality and virtual reality products, continue to pile up. The tech giant recorded $4.43B in loss from operations from the segment in Q3 2025, and its cumulative losses now total $73.04B.</p>\n<p>See the chart below:</p>\n<figure class=\"regular-img-figure\" contenteditable=\"false\"><img alt=\"Meta Reality Labs losses\" data-caption=\"\" data-original-src=\"https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png\" data-rel=\"lightbox\" data-source=\"Meta Platforms\" fetchpriority=\"high\" height=\"540\" sizes=\"(max-width: 768px) calc(100vw - 36px), (max-width: 1024px) calc(100vw - 180px), 552px\" src=\"https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png?io=w640\" srcset=\"https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png?io=w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png?io=w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png?io=w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png?io=w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png?io=w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png?io=w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png?io=w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png?io=w240 240w\" width=\"900\"/><figcaption class=\"overlay-title\"><p class=\"item-caption\"><span class=\"item-source\">Meta Platforms</span></p></figcaption></figure><p>It should be noted that META stock's Thursday slide comes after a strong run that saw a nine-session <a href=\"https://seekingalpha.com/symbol/META/historical-price-quotes\" target=\"_blank\" title=\"win streak\">win streak</a>. META's selloff also <a href=\"https://seekingalpha.com/news/4511472-metas-selloff-affects-over-600-etfs-but-these-10-funds-have-the-most-exposure\" target=\"_blank\" title=\"affects\">affects</a> more than 600 exchange-traded funds.   </p>\n</body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/36a2e31179e2dfa8ea444ad56f598144.png?io=w640",
            "link": "https://seekingalpha.com/news/4511607-meta-sheds-220b-in-market-cap-vr-unit-hits-73b-in-cumulative-losses",
            "pub_date": "2025-10-31 02:06:07",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511592",
            "title": "Fiserv stock extends decline as details of strategy overhaul, guidance reset emerge",
            "description": "<html><body><p>Fiserv (<span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/FI\" title=\"Fiserv, Inc.\">FI</a></span></span>) stock <span style=\"color: #ff0000;\">fell 7.1% </span>in Thursday afternoon trading, as a media report disclosed that the company's small-merchant customers were getting fed up with the extra fees attached to the Clover payment systems. That followed the stock's 44% plunge on Wednesday, sparked by a strategy and <a href=\"https://seekingalpha.com/news/4510095-fiserv-shakes-up-leadership-board-after-big-q3-earnings-miss-stock-plunges-30\" target=\"_blank\" title=\"eadership revamp and slashed guidance\">leadership revamp and slashed guidance</a> for Q4 2025.</p>\n<p>Bloomberg News, citing people familiar with the matter, reported on Thursday that those small business customers were looking for cheaper alternatives, such as Toast (<a href=\"https://seekingalpha.com/symbol/TOST\" title=\"Toast, Inc.\">TOST</a>) or Block's (<a href=\"https://seekingalpha.com/symbol/XYZ\" title=\"Block, Inc.\">XYZ</a>) Square systems, to handle their point-of-sale payments.</p>\n<p>What's more, former CEO Frank Bisignano based a good part of his guidance for the company's future growth on Clover outperforming rivals, the article <a href=\"https://www.bloomberg.com/news/articles/2025-10-30/fiserv-s-30-billion-wipeout-came-after-client-revolt-over-fees\" rel=\"nofollow\" target=\"_blank\" title=\"said.\">said.</a></p>\n<p>Once Mike Lyons succeeded Bisignano as CEO, he launched his own in-depth analysis of the company's merchant and banking businesses. As a result, Fiserv (<a href=\"https://seekingalpha.com/symbol/FI\" title=\"Fiserv, Inc.\">FI</a>) reset expectations when it released Q3 earnings and unveiled its One Fiserv initiative to refocus on the client. Part of that plan means rolling back fees it introduced in last year's Q4 because they're <a href=\"https://seekingalpha.com/article/4834633-fiserv-inc-fi-q3-2025-earnings-call-transcript\" target=\"_blank\" title=' \"no longer consistent '> \"no longer consistent </a>with our business strategy,\" Lyons said during the company's earnings call.</p>\n<p>In other words, the company has shifted to the long game instead of making a quick buck to juice the current quarter's results. \"We have made the decision to deprioritize these short-term revenue and expense initiatives, which, of course, has some near-term impact on our growth and profitability,\" the CEO said.</p>\n<p>Bisignano, though, doesn't think the goals he set were too high, Bloomberg reported, citing people familiar with his thinking.</p>\n<p>The new strategy means \"the revenue base is likely to be smaller, and the expense base will be bigger as Fiserv spends to address underinvestment in recent years,\" Goldman Sachs Will Nance wrote in a note to clients.</p>\n<p>Morgan Stanley analyst James Faucette had sensed dissatisfaction with Clover's small and medium business (\"SMB\") customers in its survey from April but didn't give it sufficient weight at the time. \"Our SMB Survey from April clearly indicated that the Fiserv SMB customers were very unhappy with those price increases,\" with Clover solution having among the lowest satisfaction ratings from surveyed customers, he wrote in a note to clients. That \"translated into very high expected rates of switching vs. the rest of the peer group.\"</p>\n<p>The strategy and management overhaul announced on Wednesday also damaged investor trust, according to analysts.  At least three shops<a href=\"https://seekingalpha.com/news/4511340-fiserv-downgraded-at-morgan-stanley-goldman-sachs-to-hold-equivalent\" target=\"_blank\" title=\" have downgraded Fiserv \"> have downgraded Fiserv </a> (<a href=\"https://seekingalpha.com/symbol/FI\" title=\"Fiserv, Inc.\">FI</a>) to Hold-equivalent ratings from Buy. \"Management highlighted how FI has been over-earning with short-term revenue targets and deferred investments,\" said BTIG analyst Andrew Harte. \"We expect that detail to result in a long road ahead for rebuilding investor trust/confidence.\"</p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511592-fiserv-stock-extends-decline-as-details-of-strategy-overhaul-guidance-reset-emerge",
            "pub_date": "2025-10-31 02:06:07",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511626",
            "title": "DSGR signals margin expansion and strategic investments as Q3 revenue rises 10.7%",
            "description": "<html><body><p>Earnings Call Insights: Distribution Solutions Group (DSGR) Q3 2025</p>\n<h3>Management View</h3>\n<ul>\n<li><p>CEO John King highlighted, \"Our third quarter results demonstrate the strength and resilience of our business model, even as inflation, tariffs and higher interest rates continue to challenge parts of the U.S. economy.\" King stated the organization is actively driving initiatives for long-term profitability and growth, not waiting for market tailwinds. The company delivered 10.7% revenue growth, supported by strong organic sales and contributions from 2024 acquisitions, with average daily sales up 6%. He noted, \"This represents the fourth quarter in a row that we've realized an organic sales increase and puts our year-to-date organic sales increase at 4% over 2024.\"</p></li>\n<li><p>King reported adjusted earnings per share of $0.40 for the third quarter, an 8.1% increase year-over-year, and over $20 million in share buybacks during the first nine months of 2025. Operating cash flow exceeded $38 million for the quarter, and EBITDA reached $48.5 million. EBITDA margins were 9.4%, affected by product and customer mix as well as ongoing investments, but King expects margin improvement in future quarters.</p></li>\n<li><p>The CEO detailed strategic progress at TestEquity, citing the appointment of Barry Litwin, a new go-to-market strategy, leadership restructuring, and targeted investments in digital and e-commerce capabilities. He emphasized Gexpro Services' record quarter, organic revenue expansion of 11.4%, and growing customer interest, especially amid tariff-driven demand for domestic manufacturing.</p></li>\n<li><p>For Lawson, King acknowledged, \"Although we are not satisfied with our total sales performance for Lawson this quarter, we know that economic pressures have negatively influenced many of our customers this year.\" However, he cited positive momentum in sales force transformation, expanded CRM adoption, and growth in the 24/7 web platform.</p></li>\n<li><p>CFO Ronald Knutson stated, \"DSG's consolidated revenue for the third quarter was $518 million, a 10.7% increase. The $49.9 million increase was driven by a combination of strong organic daily sales increase of 6% and $23.3 million in revenue from our 2024 acquisitions.\" Knutson also reported, \"Adjusted EBITDA dollars were essentially flat versus the second quarter and 30 basis points lower, primarily due to product and customer mix shifts, strategic investments in the business and higher employee-related costs.\"</p></li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li><p>King described a \"cautious outlook given tougher year-over-year comparisons\" for Q4 but noted, \"Business activity remains steady, and I remain confident in our leadership teams and their ability to execute on their respective value-driving initiatives.\"</p></li>\n<li><p>In the Q&amp;A, Knutson explained, \"We're not seeing any dramatic shifts, although as the third quarter developed, September was our strongest month within the quarter as well.\"</p></li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li><p>DSG reported consolidated revenue of $518 million for Q3 2025. Adjusted EBITDA was $48.5 million, representing 9.4% of sales. Net income per diluted share (GAAP) was $0.14. Non-GAAP adjusted EPS was $0.40, up 8.1% year-over-year and up from $0.35 in Q2.</p></li>\n<li><p>Cash flow from operations was $38.4 million for the quarter. The company repurchased approximately 670,000 shares year-to-date, positively impacting EPS. Total liquidity at quarter-end was $335 million, and debt leverage stood at 3.5x.</p></li>\n<li><p>Segment highlights included: Lawson Q3 sales of $121.5 million and adjusted EBITDA of $14 million (11.5% of sales); Canadian segment sales of $60 million, with $5.8 million adjusted EBITDA (9.6% of sales); Gexpro Services revenue of $130.5 million and record adjusted EBITDA of $17.8 million (13.6% of sales); TestEquity sales of $206.5 million, adjusted EBITDA of $12.4 million (6% of sales).</p></li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li><p>Thomas Moll, Stephens: Asked for clarification on Q4 outlook and organic pacing in October. Knutson responded that October's average daily sales are tempered due to more selling days but noted, \"We're not seeing any dramatic shifts...September was our strongest month within the quarter as well.\"</p></li>\n<li><p>Moll inquired about consolidated EBITDA margin guidance versus the 9.4% just reported. Knutson indicated, \"...about 30 bps of that are investments that we're making into the -- that we continue to make into the organization... probably 80 bps of that more towards... timing or nonrecurring type of items.\"</p></li>\n<li><p>Moll asked about Gexpro's growth durability. King said, \"Gexpro has got a pretty broad base of wallet share and new customer wins that it's continuing to enjoy... it feels very good, and it feels resilient.\"</p></li>\n<li><p>Moll asked for an update on Lawson sales force initiatives. King acknowledged ongoing transformation, noting metrics are improving but onboarding of new sellers is slower than expected.</p></li>\n<li><p>Kenneth Newman, KeyBanc: Asked about tariff-based pricing benefits. King said, \"This quarter was -- had strong volume growth, not just revenue growth. And so that was for the first time across all of our verticals, we enjoyed volume growth again.\"</p></li>\n<li><p>Newman followed up on labor-related margin headwinds at Lawson and TestEquity. King cited deliberate SG&amp;A investments to drive future growth.</p></li>\n<li><p>Kevin Steinke, Barrington: Asked about Canada branch margin sustainability. Knutson replied, \"Bolt continues to perform really well in that 13%, 14% margin rate... we should be above 10%. Again, we -- it's -- we're well on our way. We're not where we want to be yet.\"</p></li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li><p>Analysts expressed cautious optimism, frequently probing about margin sustainability and the pace of transformation, but did not display overt skepticism or negativity.</p></li>\n<li><p>Management maintained a confident and constructive tone in prepared remarks, shifting to detailed explanations and some acknowledgment of challenges in Q&amp;A, particularly regarding pace of sales force productivity and mix-driven margin pressures.</p></li>\n<li><p>Compared to the previous quarter, management's tone remained confident but with increased emphasis on near-term caution and operational headwinds, while analysts retained a neutral to slightly positive stance.</p></li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li><p>The company achieved higher revenue growth (10.7% in Q3 vs. 14.3% in Q2), though organic growth improved (6% in Q3 vs. 3.3% in Q2). Adjusted EBITDA margin was slightly lower in Q3 (9.4% vs. 9.7% in Q2), attributed to mix and investment costs.</p></li>\n<li><p>Management language shifted from highlighting sequential margin improvements in Q2 to more focus on ongoing investments and mix-driven headwinds in Q3.</p></li>\n<li><p>Analysts in both quarters focused on margin sustainability, transformation progress, and segment-specific drivers, but Q3 saw more questions about timing and pace of improvements.</p></li>\n<li><p>Strategic focus in Q3 included deeper investment in e-commerce, sales force, and integration initiatives, with continued emphasis on acquisition-driven growth and margin expansion.</p></li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li><p>Management cited inflation, tariffs, and higher interest rates as ongoing macroeconomic challenges.</p></li>\n<li><p>Investments in sales force expansion, leadership, and digital capabilities may introduce short-term margin pressure.</p></li>\n<li><p>Customer and product mix shifts continue to impact margins, particularly in TestEquity and Lawson.</p></li>\n<li><p>Analysts flagged the pace of sales force productivity improvements and mix-driven margin volatility as key concerns.</p></li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Management reiterated its confidence in the company’s ability to drive long-term value through disciplined execution of strategic initiatives, continued organic growth, and targeted investments in capabilities and acquisitions. The company remains focused on improving profitability, operational efficiency, and market positioning despite macroeconomic headwinds and anticipates margin expansion as recent and ongoing investments begin to yield returns.</p>\n<p><a href=\"https://seekingalpha.com/symbol/dsgr/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511626-dsgr-signals-margin-expansion-and-strategic-investments-as-q3-revenue-rises-10_7-percent",
            "pub_date": "2025-10-31 02:00:59",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511606",
            "title": "WPP stock tumbles after company cuts 2025 outlook as weaker client spending drags Q3 sales",
            "description": "<html><body><p>WPP (<span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/WPP\" title=\"WPP plc\">WPP</a></span></span>) on Thursday reported a decline in its revenue for the third quarter, weighed by softer client spending and a downturn in its media operations, prompting the advertising group to trim its full-year guidance.</p>\n<p>Revenue for the quarter fell 8.4% to £3.26 billion, down 3.5% on a like-for-like (LFL) basis, while year-to-date revenue declined 2.8% LFL.</p>\n<p>The London-based advertising giant now expects 2025 LFL revenue to fall between 5.5% and 6.0%, compared with its earlier forecast of a 3% to 5% drop. It also sees a headline operating margin of around 13%, versus prior guidance for a 50–175 basis-point decline year-on-year, excluding currency effects. WPP maintained its forecast for adjusted operating cash flow before working capital at £1.1 billion to £1.2 billion.</p>\n<p>Performance in the quarter was hit by a step down in its WPP Media division, where revenue fell 5.7% LFL, and by weaker trends in North America and the UK. India grew 6.7%, offset by a 10.6% decline in China, the company said.</p>\n<p>Shares are trading <span style=\"color: #ff0000;\">15% lower</span>. </p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511606-wpp-stock-tumbles-after-company-cuts-2025-outlook-as-weaker-client-spending-drags-q3-sales",
            "pub_date": "2025-10-31 02:00:59",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511620",
            "title": "National Beverage begins stock buyback amid market headwinds",
            "description": "<html><body><ul>\n<li>National Beverage (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/FIZZ\" title=\"National Beverage Corp.\">FIZZ</a></span>) on Thursday said it had begun open market purchases of its common stock under its previously announced share repurchase program.</li>\n<li>The company said it remains financially strong despite pressures from geopolitical factors, a U.S. government shutdown, tariffs, and weaker consumer spending affecting the beverage sector.</li>\n<li>National Beverage said it views current market conditions as temporary and believes its shares are undervalued.</li>\n<li>FIZZ is <span style=\"color: green;\">+2.30%</span> to $33.22.</li>\n<li>Source: <a href=\"https://seekingalpha.com/pr/20286940-national-beverage-corp-announces-commencement-of-stock-buyback-and-addresses-market\">Press Release</a>\n</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511620-national-beverage-begins-stock-buyback-amid-market-headwinds",
            "pub_date": "2025-10-31 01:56:02",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511618",
            "title": "NN projects $40M in new program run-rate through 2026 launches as M&A and refinancing efforts intensify",
            "description": "<html><body><p>Earnings Call Insights: NN, Inc. (NNBR) Q3 2025</p>\n<h3>Management View</h3>\n<ul>\n<li>CEO Harold Bevis emphasized the company's structured sales growth program, reporting over $180 million in new business secured and a sales pipeline now over $850 million with a closed opportunity hit rate above 20%. Bevis stated, \"We've had no cancellations of any of these new wins, just some pushouts.\" He highlighted foundational wins in defense and medical, each potentially contributing over $5 million annually and noted the company is at \"the bottom of the bathtub curve for our served markets and customers.\"</li>\n<li>The company is actively pursuing strategic M&amp;A, evaluating multiple acquisition targets to accelerate growth and scale, while formally initiating refinancing discussions for its preferred equity. Bevis explained, \"We're getting ready to embark upon that now...any acquisition we do of any size at all requires a refinancing discussion.\"</li>\n<li>Quarterly sales were reported at $104 million, with growth in power solutions and aerospace, defense, and electronics offset by headwinds in mobile solutions and automotive rationalization. Adjusted operating income reached $4 million, and adjusted EBITDA increased 7.9% year-over-year on a lower sales base. \"Our margin is up 170 basis points year-over-year,\" said Bevis, also noting $9 million in free cash flow generation.</li>\n<li>CFO Christopher Bohnert detailed, \"Net sales for the quarter were $103.9 million, declining $9.7 million versus last year's third quarter...adjusted operating income for the third quarter was $4 million, marking a strong increase...compared to $1.3 million in the prior year third quarter.\"</li>\n<li>COO Tim French stated, \"Our adjusted EBITDA margins have expanded 260 basis points since the launch of our transformational plan in early '23...We've reduced our overall headcount by more than 20%, more appropriately aligning our resources to the needs of the company.\"</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>Bevis reiterated guidance with a slight reduction in sales outlook due to lower automotive expectations, balanced by higher defense projections, resulting in minimal impact to gross margin dollars: \"We're lowering them a bit...lowering our outlook for automotive but increasing our outlook in defense.\"</li>\n<li>The company remains on track to achieve its target for new wins, with a pipeline exceeding $750 million and the largest portion not tied to automotive. Bevis stated, \"We're on track.\"</li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li>Net sales for the quarter were $103.9 million. Adjusted operating income was $4 million, up from $1.3 million in the prior year. Adjusted EBITDA reached $12.4 million, with margins at 11.9% of net sales, a 170-basis point increase year-over-year.</li>\n<li>In the Power Solutions segment, net sales were $44.9 million, up from $42.9 million last year. Adjusted EBITDA for this segment was $8.9 million, with margins rising approximately 500 basis points year-over-year.</li>\n<li>The Mobile Solutions segment saw net sales of $59.1 million, compared to $70.7 million last year, mainly due to rationalization and lower North American volumes. Adjusted EBITDA was $6.7 million, with margins at 11.4%.</li>\n<li>Free cash flow for the quarter was $9 million, with net working capital below $80 million, a 21% improvement from Q2 '23.</li>\n<li>Over 100 new programs are set to launch in 2025, with more than 70 scheduled for 2026. Forecasted contribution is approximately $26 million for 2025 and an estimated $40 million at full run-rate.</li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Robert Brown, Lake Street Capital: Asked about data center demand in power solutions and gross margin targets. Bevis responded that data center needs are driving grid demand, despite federal funding delays, and cited gold prices as a variable affecting margins.</li>\n<li>John Franzreb, Sidoti: Inquired about revenue forecast adjustments and facility rationalization impact. Bevis said rationalization will be a 2026 event with no 2025 sales impact. On capacity utilization, French indicated significant available capacity, with power at about 60% utilization and mobile varying by facility.</li>\n<li>Franzreb also asked about M&amp;A versus preferred elimination. Bevis stressed both are priorities, with no single path chosen and external advisory support being assembled.</li>\n<li>Michael Crawford, B. Riley: Queried about China operations and free cash flow expectations. Bevis described the China JV as successful, with $130 million in sales and over $30 million in EBITDA. Looking ahead, Bevis expects free cash flow to strengthen in 2026, targeting around $10 million absent the CARES refund.</li>\n<li>Barry Haimes, Sage Asset: Asked about 2026 expectations. Bevis described regional automotive growth variations and highlighted that foundational wins in medical and defense will support segment growth, with commercial vehicle improvement anticipated in the second half.</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analysts maintained a constructive but cautious tone, focusing on segment performance, capital allocation, and execution of growth and cost initiatives. Questions sought clarity on guidance, margin drivers, and capacity, reflecting a neutral to slightly positive sentiment.</li>\n<li>Management's tone was confident in prepared remarks, frequently referencing progress and strategic wins. In Q&amp;A, responses became more detailed and occasionally cautious, especially when addressing sector headwinds and macro uncertainty. Bevis acknowledged, \"We're not at liberty to discuss the plant,\" and \"We're not sitting on a big pile of cash,\" indicating some defensiveness.</li>\n<li>Compared to the previous quarter, management maintained a similar level of confidence, but with heightened attention to mix shifts and external headwinds. Analysts' tone remained consistently inquisitive, with continued focus on execution and risk management.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>The company reduced its sales outlook due to automotive softness but increased defense expectations. Portfolio mix shifts were highlighted as a mitigating factor for margins.</li>\n<li>Strategic focus has shifted further toward M&amp;A and refinancing activities, with management reporting meaningful progress in pipeline development and organization.</li>\n<li>Analysts continued to focus on margin expansion, capital structure optimization, and the ramp-up of new business, similar to the previous quarter.</li>\n<li>Adjusted EBITDA margins and free cash flow both improved sequentially, while leadership reiterated long-term margin targets and confidence in transformation programs.</li>\n<li>Management's tone in both quarters reflected ongoing confidence, but the current quarter showed increased transparency about macro risks and operational adjustments.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Management cited softness in the North American automotive market, volatility in electrical infrastructure funding, high inflation in precious metals, and commercial vehicle industry recalibration as ongoing headwinds.</li>\n<li>Mitigation efforts include cost reductions, working capital improvements, focused new business development, and continued rationalization of underperforming assets.</li>\n<li>Analysts raised concerns about the pace of M&amp;A, timing of facility rationalizations, and the impact of federal funding delays.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>NN, Inc. management underscored that while market headwinds and sector volatility persist, the company is driving margin and cash flow improvements through operational restructuring, disciplined cost management, and an aggressive new business acquisition program. With foundational wins in key growth sectors, ongoing strategic M&amp;A and refinancing initiatives, and a robust pipeline of program launches expected to deliver up to $40 million in new run-rate revenues, leadership maintains a positive outlook for sustainable value creation through 2026 and beyond.</p>\n<p><a href=\"https://seekingalpha.com/symbol/nnbr/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511618-nn-projects-40m-in-new-program-run-rate-through-2026-launches-as-m-and-a-and-refinancing",
            "pub_date": "2025-10-31 01:50:42",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511597",
            "title": "Tech Voices: China, Bessent on TikTok deal; OpenAI's IPO",
            "description": "<html><body><p dir=\"ltr\"><em>Seeking Alpha's roundup of statements, announcements, and remarks that could impact the technology sector.</em></p>\n<ul><li dir=\"ltr\">China plans to work with the U.S. to resolve issues related to TikTok's U.S. operations, which are currently owned by China's ByteDance (<a href=\"https://seekingalpha.com/symbol/BDNCE\" title=\"ByteDance\">BDNCE</a>).</li></ul>\n<p dir=\"ltr\">\"Both sides further affirmed the outcomes of the Madrid trade consultations, with the U.S. side making positive commitments in areas such as investment, and China agreeing to work with the U.S. to properly resolve issues related to TikTok,\" China's Commerce Ministry <a href=\"https://www.mofcom.gov.cn/xwfb/xwfyrth/art/2025/art_c42035acf50846ffb9fb4761ee224faf.html\" rel=\"nofollow\">said in a statement</a>.</p>\n<p dir=\"ltr\">The announcement comes in the wake of trade talks between U.S. and Chinese representatives in Kuala Lumpur earlier this week. </p>\n<ul><li dir=\"ltr\">Meanwhile, Treasury Secretary Scott Bessent said the Chinese government has okayed the transfer of TikTok's U.S. operations, but didn't disclose any details.</li></ul>\n<p dir=\"ltr\">\"In Kuala Lumpur, we finalized the TikTok agreement in terms of getting Chinese approval, and I would expect that would go forward in the coming weeks and months, and we'll finally see a resolution to that,\" Bessent said, <a href=\"https://www.reuters.com/world/china/china-us-trade-deal-could-be-signed-next-week-us-treasurys-bessent-says-2025-10-30/\" rel=\"nofollow\">according to Reuters</a>.</p>\n<ul><li dir=\"ltr\">OpenAI (<a href=\"https://seekingalpha.com/symbol/OPENAI\" title=\"OpenAI\">OPENAI</a>) is readying an IPO that could value the AI developer as high as $1 trillion. </li></ul>\n<p dir=\"ltr\">The company is considering aiming to raise at least $60 billion through the deal. OpenAI could file for the IPO as soon as the second half of 2026, <a href=\"https://www.reuters.com/world/china/china-us-trade-deal-could-be-signed-next-week-us-treasurys-bessent-says-2025-10-30/\" rel=\"nofollow\">according to Reuters</a>, who cited people close to the deal. </p>\n<p dir=\"ltr\">OpenAI counts Microsoft (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a></span>) as a major investor.</p>\n<p><strong id=\"docs-internal-guid-5d773449-7fff-45cd-d593-8e225ed27fc5\"></strong></p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511597-tech-voices-china-bessent-on-tiktok-deal-openais-ipo",
            "pub_date": "2025-10-31 01:50:42",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}